홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
KURA
#2592
Kura Oncology, Inc.
9.2
5
USD
+1.20%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.20%
월간 변동
+6.69%
6달 변화
-10.89%
년간 변동율
+54.17%
이전 종가
9.1
4
Open
9.2
3
Bid
Ask
Low
9.1
9
High
9.2
7
양
72
마켓
주식
헬스케어
KURA
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
66.21 M
66.61 M
68.44 M
76.14 M
80.75 M
88.33 M
—
Valuation ratios
Enterprise value
1.84 B
846.18 M
782.04 M
1.14 B
488.44 M
778.36 M
2.42 B
Price to earnings ratio
—
—
-5.94
-7.38
-4.31
-3.27
-12.57
Price to sales ratio
—
—
—
—
13.93
13.5
—
Price to cash flow ratio
—
—
-7.33
-9.01
5.59
-14.22
3.14
Price to book ratio
—
—
1.92
2.83
1.81
5.23
6.49
EBITDA 비율에 대한 기업 가치
—
-6.74
—
—
-2.4
-2.54
—
Profitability ratios
Return on assets %
-0.14
-0.24
-0.3
-0.34
-0.23
-0.38
-0.4
Return on equity %
-0.15
-0.26
-0.32
-0.38
-0.42
-1.6
-1.14
Return on invested capital %
-4 731.27
-4 261.24
-4 669.95
-4 398.28
-2 520.1
-1 522.22
-1 640.21
Gross margin %
—
100
—
—
100
100
400
Operating margin %
—
62.01 K
—
—
-358.55
-449.94
-1 817.07
EBITDA margin %
—
59.68 K
—
—
-380.39
-460.23
-1 860.26
Net margin %
—
61.54 K
—
—
-322.89
-412.95
-1 663.99
Liquidity ratios
Quick ratio
—
—
—
—
—
6.05
—
Current ratio
24.49
23.26
18.56
12.26
9.46
6.06
25.4
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
-0
—
—
0.09
0.09
0.1
Solvency ratios
Debt to assets ratio
0.01
0.01
0.02
0.02
0.01
0.01
0.06
Debt to equity ratio
0.01
0.01
0.02
0.02
0.02
0.06
0.15
Long term debt to total assets ratio
0.01
0.01
0.02
0.02
0.01
0.01
0.04
Long term debt to total equity ratio
0.01
0.01
0.02
0.02
0.02
0.06
0.12
Per share metrics
Operating cash flow per share
—
—
-1.64
-1.7
1.56
-0.73
-0.73
EBIT per share
—
—
—
—
-2.24
-3.46
-3.47
EBITDA per share
—
—
—
—
-2.38
-3.54
-3.55
Total debt per share
—
—
0.14
0.13
0.11
0.11
0.44
Cash per share
—
—
6.54
5.79
8.44
7.61
28.61
Net current asset value per share
—
—
6.66
5.91
8.64
8.08
30.99
Tangible book value per share
—
—
6.27
5.43
4.8
1.99
12.41
Working capital per share
—
—
6.3
5.42
7.73
6.75
26.02
Book value per share
—
—
6.27
5.43
4.8
1.99
12.41
뉴스
Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)
UBS, Kura Oncology 목표 주가 15달러로 하향 조정
UBS lowers Kura Oncology stock price target to $15 on launch data
쿠라 온콜로지, Leerink 글로벌 헬스케어 컨퍼런스 참가: 전략적 확장 인사이트
Kura Oncology at Leerink Global Healthcare Conference: Strategic Expansion Insights
Kura Oncology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:KURA) 2026-03-06
쿠라 온콜로지, 견조한 출시로 Citizens 투자의견 재확인
Citizens reiterates Kura Oncology stock rating on strong launch
Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates
Kura Oncology Inc Q1 실적, 수익 에상치보다 저조
Kura Oncology Inc earnings missed by $0.66, revenue fell short of estimates
Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline